Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Endostar (recombinant human endostatin)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Simcere

Drug class:

VEGF inhibitor

Related drugs:

‹

ivonescimab (3)

autologous activated lymphocytes (0)

STAR-LLD SC (0)

ivonescimab (3)

autologous activated lymphocytes (0)

STAR-LLD SC (0)

›

KDR expression	Cervical Cancer	KDR expression	Cervical Cancer	recombinant human endostatin Sensitive: C3 – Early Trials recombinant human endostatin Sensitive : C3	recombinant human endostatin Sensitive: C3 – Early Trials recombinant human endostatin Sensitive : C3
EGFR negative + ALK negative	Non Small Cell Lung Cancer	EGFR negative + ALK negative	Non Small Cell Lung Cancer	recombinant human endostatin Sensitive: C3 – Early Trials recombinant human endostatin Sensitive : C3	recombinant human endostatin Sensitive: C3 – Early Trials recombinant human endostatin Sensitive : C3
EGFR negative + ALK negative + PD-L1 expression	Non Small Cell Lung Cancer	EGFR negative + ALK negative + PD-L1 expression	Non Small Cell Lung Cancer	recombinant human endostatin Sensitive: C3 – Early Trials recombinant human endostatin Sensitive : C3	recombinant human endostatin Sensitive: C3 – Early Trials recombinant human endostatin Sensitive : C3
EGFR L858R + ROS1 fusion	Non Small Cell Lung Cancer	EGFR L858R + ROS1 fusion	Non Small Cell Lung Cancer	recombinant human endostatin Sensitive: C4 – Case Studies recombinant human endostatin Sensitive : C4	recombinant human endostatin Sensitive: C4 – Case Studies recombinant human endostatin Sensitive : C4
ERRFI1 T187A	Ovarian Cancer	ERRFI1 T187A	Ovarian Cancer	rivoceranib + recombinant human endostatin Sensitive: C4 – Case Studies rivoceranib + recombinant human endostatin Sensitive : C4	rivoceranib + recombinant human endostatin Sensitive: C4 – Case Studies rivoceranib + recombinant human endostatin Sensitive : C4